National Bank of Canada’s Briacell Therapeutics BCTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.43K | Sell |
65
-29
| -31% | -$638 | ﹤0.01% | 2289 |
|
2025
Q1 | $2.86K | Buy |
94
+43
| +84% | +$1.31K | ﹤0.01% | 2137 |
|
2024
Q4 | $4.36K | Sell |
51
-1
| -2% | -$85 | ﹤0.01% | 2091 |
|
2024
Q3 | $9.66K | Buy |
52
+2
| +4% | +$371 | ﹤0.01% | 1904 |
|
2024
Q2 | $8.03K | Hold |
50
| – | – | ﹤0.01% | 2021 |
|
2024
Q1 | $16.7K | Hold |
50
| – | – | ﹤0.01% | 1871 |
|
2023
Q4 | $40K | Buy |
50
+33
| +194% | +$26.4K | ﹤0.01% | 1669 |
|
2023
Q3 | $14.9K | Hold |
17
| – | – | ﹤0.01% | 1882 |
|
2023
Q2 | $15.9K | Hold |
17
| – | – | ﹤0.01% | 1896 |
|
2023
Q1 | $18.5K | Hold |
17
| – | – | ﹤0.01% | 1855 |
|
2022
Q4 | $10.9K | Buy |
+17
| New | +$10.9K | ﹤0.01% | 1994 |
|
2022
Q3 | – | Sell |
-119
| Closed | -$103K | – | 2509 |
|
2022
Q2 | $103K | Sell |
119
-927
| -89% | -$802K | ﹤0.01% | 1368 |
|
2022
Q1 | $1.59M | Buy |
1,046
+847
| +426% | +$1.29M | ﹤0.01% | 788 |
|
2021
Q4 | $248K | Buy |
+199
| New | +$248K | ﹤0.01% | 1227 |
|